Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linqi Zhang

Showing results (241-250 of 279) with videos related to

Pageof 28
Sort By:
Vaccine|July 5, 2005
SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirusPatrick C Y Woo, Susanna K P Lau, Hoi-Wah Tsoi, et al.
Cell|July 31, 2020
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and AntigenicityQianqian Li, Jiajing Wu, Jianhui Nie, et al.
Frontiers in Immunology|October 3, 2022
Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2Yun Ji, Qi Zhang, Lin Cheng, et al.
Virology|November 7, 2008
Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibodyChao Bian, Xiuqin Zhang, Xingfeng Cai, et al.
Science Translational Medicine|December 20, 2023
Liver macrophages and sinusoidal endothelial cells execute vaccine-elicited capture of invasive bacteriaJuanjuan Wang, Haoran An, Ming Ding, et al.
Immunity|November 4, 2023
Dissecting the intricacies of human antibody responses to SARS-CoV-1 and SARS-CoV-2 infectionRuoke Wang, Yang Han, Rui Zhang, et al.
The Journal of Clinical Investigation|February 21, 2018
Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized miceXilin Wu, Jia Guo, Mengyue Niu, et al.
Nature Communications|January 12, 2021
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicryJiwan Ge, Ruoke Wang, Bin Ju, et al.
Frontiers in Immunology|December 30, 2021
A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 VariantsSisi Shan, Chee Keng Mok, Shuyuan Zhang, et al.
NPJ Vaccines|December 31, 2024
DS2 designer pre-fusion F vaccine induces strong and protective antibody response against RSV infectionYiling Yang, Ruoke Wang, Fenglin Guo, et al.
Pageof 28

Showing results (241-250 of 279) with videos related to

Sort By:
Pageof 28
Vaccine|July 5, 2005
SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirusPatrick C Y Woo, Susanna K P Lau, Hoi-Wah Tsoi, et al.
Cell|July 31, 2020
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and AntigenicityQianqian Li, Jiajing Wu, Jianhui Nie, et al.
Frontiers in Immunology|October 3, 2022
Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2Yun Ji, Qi Zhang, Lin Cheng, et al.
Virology|November 7, 2008
Conserved amino acids W423 and N424 in receptor-binding domain of SARS-CoV are potential targets for therapeutic monoclonal antibodyChao Bian, Xiuqin Zhang, Xingfeng Cai, et al.
Science Translational Medicine|December 20, 2023
Liver macrophages and sinusoidal endothelial cells execute vaccine-elicited capture of invasive bacteriaJuanjuan Wang, Haoran An, Ming Ding, et al.
Immunity|November 4, 2023
Dissecting the intricacies of human antibody responses to SARS-CoV-1 and SARS-CoV-2 infectionRuoke Wang, Yang Han, Rui Zhang, et al.
The Journal of Clinical Investigation|February 21, 2018
Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized miceXilin Wu, Jia Guo, Mengyue Niu, et al.
Nature Communications|January 12, 2021
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicryJiwan Ge, Ruoke Wang, Bin Ju, et al.
Frontiers in Immunology|December 30, 2021
A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 VariantsSisi Shan, Chee Keng Mok, Shuyuan Zhang, et al.
NPJ Vaccines|December 31, 2024
DS2 designer pre-fusion F vaccine induces strong and protective antibody response against RSV infectionYiling Yang, Ruoke Wang, Fenglin Guo, et al.
Pageof 28